Sasongko L, Williams K, Day R, McLachlan A
Br J Clin Pharmacol. 2003; 56(5):551-61.
PMID: 14651730
PMC: 1884385.
DOI: 10.1046/j.1365-2125.2003.01930.x.
Maglio D, Teng R, Thyrum P, Nightingale C, Nicolau D
Antimicrob Agents Chemother. 2003; 47(5):1771-3.
PMID: 12709358
PMC: 153322.
DOI: 10.1128/AAC.47.5.1771-1773.2003.
Williams D, Raymond J
Clin Pharmacokinet. 1998; 35(1):65-77.
PMID: 9673835
DOI: 10.2165/00003088-199835010-00005.
Scaglione F, De Martini G, Peretto L, GHEZZI R, Baratelli M, Arcidiacono M
Antimicrob Agents Chemother. 1997; 41(10):2292-4.
PMID: 9333066
PMC: 164111.
DOI: 10.1128/AAC.41.10.2292.
Brogden R, Spencer C
Drugs. 1997; 53(3):483-510.
PMID: 9074846
DOI: 10.2165/00003495-199753030-00009.
Distribution of systemically administered ampicillin, benzylpenicillin, and flucloxacillin in excisional wounds in diabetic and normal rats and effects of local topical vasodilator treatment.
Cross S, Thompson M, Roberts M
Antimicrob Agents Chemother. 1996; 40(7):1703-10.
PMID: 8807066
PMC: 163399.
DOI: 10.1128/AAC.40.7.1703.
Pharmacodynamic activity of a cephalosporin, Ro 40-6890, in human skin blister fluid: antibiotic activity in concert with host defense mechanisms.
Hoogkamer J, Hesse W, Sansano S, Zimmerli W
Antimicrob Agents Chemother. 1993; 37(12):2622-7.
PMID: 8109926
PMC: 192758.
DOI: 10.1128/AAC.37.12.2622.
Review of beta-lactam antibiotics in pregnancy. The need for adjustment of dosage schedules.
Heikkila A, Erkkola R
Clin Pharmacokinet. 1994; 27(1):49-62.
PMID: 7955771
DOI: 10.2165/00003088-199427010-00005.
Pharmacokinetics of intravenous cefmetazole with emphasis on comparison between predicted theoretical levels in tissue and actual skin window fluid levels.
Tan J, Salstrom S, Signs S, HOFFMAN H, FILE T
Antimicrob Agents Chemother. 1989; 33(6):924-7.
PMID: 2764542
PMC: 284256.
DOI: 10.1128/AAC.33.6.924.
Penetration of antibiotics into the surgical wound in a canine model.
Rosin E, Ebert S, Uphoff T, Evans M, Schultz-Darken N
Antimicrob Agents Chemother. 1989; 33(5):700-4.
PMID: 2751283
PMC: 172517.
DOI: 10.1128/AAC.33.5.700.
Significance of "extravascular" protein binding for antimicrobial pharmacodynamics in an in vitro capillary model of infection.
Dudley M, Blaser J, Gilbert D, Zinner S
Antimicrob Agents Chemother. 1990; 34(1):98-101.
PMID: 2327764
PMC: 171527.
DOI: 10.1128/AAC.34.1.98.
Multiple-dose pharmacokinetics of ofloxacin in serum, saliva, and skin blister fluid of healthy volunteers.
Warlich R, Korting H, Schafer-Korting M, Mutschler E
Antimicrob Agents Chemother. 1990; 34(1):78-81.
PMID: 2327762
PMC: 171523.
DOI: 10.1128/AAC.34.1.78.
Cefotaxime. An update of its pharmacology and therapeutic use.
Todd P, Brogden R
Drugs. 1990; 40(4):608-51.
PMID: 2083516
DOI: 10.2165/00003495-199040040-00008.
Comparative effect of protein binding on the killing activities of teicoplanin and vancomycin.
Bailey E, Rybak M, Kaatz G
Antimicrob Agents Chemother. 1991; 35(6):1089-92.
PMID: 1834010
PMC: 284292.
DOI: 10.1128/AAC.35.6.1089.
Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response.
Nix D, Goodwin S, Peloquin C, Rotella D, Schentag J
Antimicrob Agents Chemother. 1991; 35(10):1953-9.
PMID: 1759813
PMC: 245307.
DOI: 10.1128/AAC.35.10.1953.
Effect of protein binding in serum on therapeutic efficacy of cephem antibiotics.
Tawara S, Matsumoto S, Kamimura T, Goto S
Antimicrob Agents Chemother. 1992; 36(1):17-24.
PMID: 1590685
PMC: 189219.
DOI: 10.1128/AAC.36.1.17.